US Stock MarketDetailed Quotes
ESPR Esperion Therapeutics
- 2.080
- +0.020+0.97%
Close May 3 16:00 ET
- 2.110
- +0.030+1.44%
Post 19:46 ET
393.95MMarket Cap-1024P/E (TTM)
2.210High2.035Low5.53MVolume2.120Open2.060Pre Close11.71MTurnover2.94%Turnover RatioLossP/E (Static)189.40MShares3.40052wk High-0.87P/B391.77MFloat Cap0.70052wk Low--Dividend TTM188.35MShs Float120.960Historical High--Div YieldTTM8.50%Amplitude0.700Historical Low2.118Avg Price1Lot Size
Esperion Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 22.50%-135.49M | 12.75%-37.06M | 54.88%-19.33M | 51.02%-24.75M | -39.41%-54.36M | 33.73%-174.83M | 26.40%-42.47M | 38.07%-42.83M | -5.57%-50.53M | 56.22%-38.99M |
| Net income from continuing operations | 10.45%-209.25M | -1.54%-56.34M | 25.16%-41.25M | 24.71%-49.94M | -8.79%-61.72M | 13.17%-233.66M | 14.79%-55.49M | 20.56%-55.12M | -51.88%-66.32M | 37.61%-56.73M |
| Depreciation and amortization | -67.20%164K | -93.48%6K | -75.24%26K | -66.00%51K | -47.06%81K | -18.30%500K | -39.87%92K | -31.37%105K | -1.96%150K | 0.00%153K |
| Other non cash items | 4.69%48.38M | 6.22%12.41M | 7.33%12.35M | 2.34%11.89M | 2.84%11.74M | 30.07%46.21M | 6.15%11.68M | 5.96%11.5M | 39.20%11.62M | 114.33%11.41M |
| Change In working capital | 505.43%13.68M | 278.72%3.96M | 317.34%6.58M | 3,275.42%10.16M | -548.21%-7.02M | 93.58%-3.37M | 60.37%-2.21M | 81.42%-3.03M | 101.41%301K | 116.73%1.57M |
| -Change in receivables | -36.78%-14.77M | -162.10%-5.87M | 49.96%-1.82M | -60.70%-4.38M | -23.10%-2.69M | -2.36%-10.8M | -83.01%-2.24M | -2,631.25%-3.65M | 39.70%-2.73M | 55.85%-2.18M |
| -Change in inventory | -3,669.76%-30.42M | -150.85%-14.19M | -1,739.94%-5.76M | -198.47%-6.32M | -229.44%-4.15M | 95.58%-807K | -1,240.28%-5.66M | 96.95%-313K | 274.32%6.42M | 67.64%-1.26M |
| -Change in prepaid assets | 336.36%6.19M | 794.98%4.64M | -16.35%-2.16M | 167.34%5.32M | -310.47%-1.61M | 1,333.33%1.42M | 151.96%518K | -107.27%-1.85M | -70.97%1.99M | 115.70%764K |
| -Change in payables and accrued expense | 219.91%30.78M | 140.21%13.7M | 207.42%12.23M | 288.46%12.07M | -213.87%-7.22M | 135.40%9.62M | 240.64%5.7M | 194.58%3.98M | 71.37%-6.41M | 83.41%6.34M |
| -Change in other working capital | 879.18%21.9M | 1,155.58%5.68M | 442.46%4.09M | 240.22%3.48M | 511.90%8.65M | -160.37%-2.81M | -122.38%-538K | -11.17%-1.19M | -58.18%1.02M | -338.37%-2.1M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 22.50%-135.49M | 12.75%-37.06M | 54.88%-19.33M | 51.02%-24.75M | -39.41%-54.36M | 33.73%-174.83M | 26.40%-42.47M | 38.07%-42.83M | -5.57%-50.53M | 56.22%-38.99M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 424.43%42.5M | 0 | 0 | 250.00%17.5M | 238.11%25M | 116.05%8.1M | 76.64%-11.79M | 33M | 5M | -18.1M |
| Net investment purchase and sale | 424.43%42.5M | --0 | --0 | 250.00%17.5M | 238.11%25M | 116.05%8.1M | 76.64%-11.79M | --33M | --5M | ---18.1M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 424.43%42.5M | --0 | --0 | 250.00%17.5M | 238.11%25M | 116.05%8.1M | 76.64%-11.79M | --33M | --5M | ---18.1M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 54.76%50.46M | 114.73%4.47M | -109.31%-4.31M | -95.53%809K | 3,546.52%49.49M | -87.84%32.61M | -114.23%-30.36M | 1,166.54%46.29M | -63.13%18.11M | -170.22%-1.44M |
| Net common stock issuance | -37.40%56.88M | 138.44%52.43M | -207.82%-52.46M | -78.68%4.31M | --52.6M | -58.46%90.85M | -89.74%21.99M | 1,008.75%48.65M | --20.21M | --0 |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --9.09M | ---43.36M | --52.44M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | -201.24%-50.22M | -40,100.00%-50M | --0 | --0 | -338.00%-219K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 54.76%50.46M | 114.73%4.47M | -109.31%-4.31M | -95.53%809K | 3,546.52%49.49M | -87.84%32.61M | -114.23%-30.36M | 1,166.54%46.29M | -63.13%18.11M | -170.22%-1.44M |
| Net cash flow | ||||||||||
| Beginning cash position | -51.80%124.78M | -45.16%114.83M | -19.93%138.47M | -27.68%144.91M | -51.80%124.78M | -15.11%258.89M | 36.26%209.4M | -21.10%172.94M | -8.06%200.36M | -15.11%258.89M |
| Current changes in cash | 68.29%-42.53M | 61.49%-32.59M | -164.83%-23.64M | 76.51%-6.44M | 134.40%20.14M | -191.12%-134.12M | -180.43%-84.62M | 155.65%36.46M | -2,299.20%-27.42M | 32.74%-58.53M |
| End cash Position | -34.08%82.25M | -34.08%82.25M | -45.16%114.83M | -19.93%138.47M | -27.68%144.91M | -51.80%124.78M | -51.80%124.78M | 36.26%209.4M | -21.10%172.94M | -8.06%200.36M |
| Free cash flow | 22.50%-135.49M | 12.75%-37.06M | 54.88%-19.33M | 51.02%-24.75M | -39.41%-54.36M | 33.73%-174.83M | 26.40%-42.47M | 38.07%-42.83M | -5.57%-50.53M | 56.22%-38.99M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg